Flugen, Inc.-Arecor Partnership Enhances Promise of Universal Flu Vaccine Through Funding Award From the UK’s Innovation Agency, the Technology Strategy Board
7/30/2013 6:44:21 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
MADISON, Wis.--(BUSINESS WIRE)--Arecor Ltd of Cambridge, England received the funding to pursue a research project applying Arecor’s innovative Arestat™ formulation technology to a promising flu vaccine, REDEE FLU™, developed by FluGen, Inc., of Madison, WI. The UK’s innovation agency, the Technology Strategy Board, has awarded Arecor a Proof of Concept award through its Smart programme, to engage in research and development in the strategically important area of developing a stable formulation for REDEE FLU™.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by